Alternative Medicine Company Investment Opportunity in New Delhi, India

- Business is revolutionizing the management of chronic and neuropathic pain in India with a focus on safety and efficacy.
- Our licensed healthcare company is pioneering the country's first range of GMP-compliant, lab-certified, ayurvedic cannabinoid formulations designed to provide patients with a natural alternative to traditional pain medications.
- First mover advantage: First to bring cannabinoid based pain management solutions into mainstream healthcare and retail in India.
- Onco Range: Launched India's first and only Onco-focused range of CBD formulations addressing big problem areas in cancer care.
- Endorsement from the medical community: Extensive inroads into the medical community with KOL's prescribing and endorsing our medications.
- Backed by clinical trials: 1st Indian company to conduct clinical trials and bring CBD-based pain management products into mainstream healthcare and retail.
- Extensive distribution: Access to extensive distribution through partnerships with the largest healthcare and big box companies such as Apollo, Guardian, Genisan Healthcare, Max Group, Spencer’s Retail, and Nature Basket.
- Traction: Since last year, 9X growth in Offline sales and 3X growth in sales.
- Marquee investors onboarded from Apollo Hospital, Panthera Peak Ventures, IIFL Finance,  Mahindra First.
- The business has all the required licenses and certifications.